Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The first-appearing β-cell autoantibody has been shown to influence risk of type 1 diabetes (T1D). Here, we assessed the risk of autoantibody spreading to the second-appearing autoantibody and further progression to clinical disease in The Environmental Determinants of Diabetes in the Young (TEDDY) study. RESEARCH DESIGN AND METHODS: Eligible children with increased HLA-DR-DQ genetic risk for T1D were followed quarterly from age 3 months up to 15 years for development of a single first-appearing autoantibody (GAD antibody [GADA], insulin autoantibody [IAA], or insulinoma antigen-2 autoantibody [IA-2A]) and subsequent development of a single second-appearing autoantibody and progression to T1D. Autoantibody positivity was defined as positivity for a specific autoantibody at two consecutive visits confirmed in two laboratories. Zinc transporter 8 autoantibody (ZnT8A) was measured in children who developed another autoantibody. RESULTS: There were 608 children who developed a single first-appearing autoantibody (IAA, n = 282, or GADA, n = 326) with a median follow-up of 12.5 years from birth. The risk of a second-appearing autoantibody was independent of GADA versus IAA as a first-appearing autoantibody (adjusted hazard ratio [HR] 1.12; 95% CI 0.88–1.42; P = 0.36). Second-appearing GADA, IAA, IA-2A, or ZnT8A conferred an increased risk of T1D compared with children who remained positive for a single autoantibody, e.g., IAA or GADA second (adjusted HR 6.44; 95% CI 3.78–10.98), IA-2A second (adjusted HR 16.33; 95% CI 9.10–29.29; P < 0.0001), or ZnT8A second (adjusted HR 5.35; 95% CI 2.61–10.95; P < 0.0001). In children who developed a distinct second autoantibody, IA-2A (adjusted HR 3.08; 95% CI 2.04–4.65; P < 0.0001) conferred a greater risk of progression to T1D as compared with GADA or IAA. Additionally, both a younger initial age at seroconversion and shorter time to the development of the second-appearing autoantibody increased the risk for T1D. CONCLUSIONS: The hierarchical order of distinct autoantibody spreading was independent of the first-appearing autoantibody type and was age-dependent and augmented the risk of progression to T1D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In children with only one persistent islet autoantibody, the risk of diabetes within 10 years is 15% while two or more islet autoantibodies predict type 1 diabetes in 70% within 10 years (408,409).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [409]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children
Ziegler, A. G., Rewers, M., Simell, O., Simell, T., Lempainen, J., Steck, A., Winkler, C., Ilonen, J., Veijola, R., Knip, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.6285 · Cited by 1,312
Self-citationInsel, R. A., Dunne, J. L., Atkinson, M. A., Chiang, J. L., Dabelea, D., Gottlieb, P. A., Greenbaum, C. J., Herold, K. C., Krischer, J. P., Lernmark, Å., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1419 · Cited by 1,216
Self-citationThe cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
Wenzlau, J. M., Juhl, K., Yu, L., Moua, O., Sarkar, S. A., Gottlieb, P., Rewers, M., Eisenbarth, G. S., Jensen, J., Davidson, H. W., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705894104 · Cited by 1,014
Self-citationZiegler, A. G., Hummel, M., Schenker, M., & Bonifacio, E. (1999) · Diabetes · doi:10.2337/diabetes.48.3.460 · Cited by 645
Self-citationConcannon, P., Rich, S. S., & Nepom, G. T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0808284 · Cited by 510
Self-citationBingley, P. J., Bonifacio, E., Williams, A. J. K., Genovese, S., Bottazzo, G. F., & Gale, E. A. M. (1997) · Diabetes · doi:10.2337/diab.46.11.1701 · Cited by 461
Self-citationYu, L., Robles, D. T., Abiru, N., Kaur, P., Rewers, M., Kelemen, K., & Eisenbarth, G. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040556697 · Cited by 450
Self-citationthe TEDDY Study Group, Krischer, J. P., Lynch, K. F., Schatz, D. A., Ilonen, J., Lernmark, Å., Hagopian, W. A., Rewers, M. J., She, J.-X., Simell, O. G., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3514-y · Cited by 444
Self-citationThe Environmental Determinants of Diabetes in the Young (TEDDY) study: study design
The TEDDY Study Group (2007) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00269.x · Cited by 361
Self-citationThe Environmental Determinants of Diabetes in the Young (TEDDY) Study
TEDDY Study Group (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1447.062 · Cited by 306
Self-citationAssociation of Early Exposure of Probiotics and Islet Autoimmunity in the TEDDY Study
Uusitalo, U., Liu, X., Yang, J., Aronsson, C. A., Hummel, S., Butterworth, M., Lernmark, Å., Rewers, M., Hagopian, W., She, J.-X., et al. (2016) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2015.2757 · Cited by 292
Self-citationBonifacio, E., Yu, L., Williams, A. K., Eisenbarth, G. S., Bingley, P. J., Marcovina, S. M., Adler, K., Ziegler, A. G., Mueller, P. W., Schatz, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0293 · Cited by 291
Self-citationStratification of Type 1 Diabetes Risk on the Basis of Islet Autoantibody Characteristics
Achenbach, P., Warncke, K., Reiter, J., Naserke, H. E., Williams, A. J. K., Bingley, P. J., Bonifacio, E., & Ziegler, A.-G. (2004) · Diabetes · doi:10.2337/diabetes.53.2.384 · Cited by 280
Self-citationAge-related islet autoantibody incidence in offspring of patients with type 1 diabetes
the BABYDIAB-BABYDIET Study Group, Ziegler, A.-G., & Bonifacio, E. (2012) · Diabetologia · doi:10.1007/s00125-012-2472-x · Cited by 264
Self-citationHagopian, W. A., Erlich, H., Lernmark, Å., Rewers, M., Ziegler, A. G., Simell, O., Akolkar, B., Vogt, R., Blair, A., Ilonen, J., et al. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00774.x · Cited by 260
Self-citationOrban, T., Sosenko, J. M., Cuthbertson, D., Krischer, J. P., Skyler, J. S., Jackson, R., Yu, L., Palmer, J. P., Schatz, D., Eisenbarth, G., et al. (2009) · Diabetes Care · doi:10.2337/dc09-0934 · Cited by 260
Self-citationProspective virome analyses in young children at increased genetic risk for type 1 diabetes
the TEDDY Study Group, Vehik, K., Lynch, K. F., Wong, M. C., Tian, X., Ross, M. C., Gibbs, R. A., Ajami, N. J., Petrosino, J. F., Rewers, M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0667-0 · Cited by 235
Self-citationAntiislet autoantibodies usually develop sequentially rather than simultaneously
Yu, L. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.12.4264 · Cited by 214
Self-citationPatterns of β-Cell Autoantibody Appearance and Genetic Associations During the First Years of Life
Ilonen, J., Hammais, A., Laine, A.-P., Lempainen, J., Vaarala, O., Veijola, R., Simell, O., & Knip, M. (2013) · Diabetes · doi:10.2337/db13-0300 · Cited by 205
Self-citationAutoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk
Achenbach, P., Lampasona, V., Landherr, U., Koczwara, K., Krause, S., Grallert, H., Winkler, C., Pflüger, M., Illig, T., Bonifacio, E., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1438-0 · Cited by 199
Self-citationKrischer, J. P., Lynch, K. F., Lernmark, Å., Hagopian, W. A., Rewers, M. J., She, J.-X., Toppari, J., Ziegler, A.-G., Akolkar, B., & the TEDDY Study Group (2017) · Diabetes Care · doi:10.2337/dc17-0238 · Cited by 185
Self-citationon behalf of the TEDDY Study Group, Lönnrot, M., Lynch, K. F., Elding Larsson, H., Lernmark, Å., Rewers, M. J., Törn, C., Burkhardt, B. R., Briese, T., Hagopian, W. A., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4365-5 · Cited by 171
Self-citationRole of Type 1 Diabetes–Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study
Törn, C., Hadley, D., Lee, H. S., Hagopian, W., Lernmark, Å., Simell, O., Rewers, M., Ziegler, A. G., Schatz, D., Akolkar, B., et al. (2014) · Diabetes · doi:10.2337/db14-1497 · Cited by 162
Self-citationPredicting Islet Cell Autoimmunity and Type 1 Diabetes: An 8-Year TEDDY Study Progress Report
Krischer, J. P., Liu, X., Vehik, K., Akolkar, B., Hagopian, W. A., Rewers, M. J., She, J.-X., Toppari, J., Ziegler, A.-G., Lernmark, Å., et al. (2019) · Diabetes Care · doi:10.2337/dc18-2282 · Cited by 122
Self-citationYu, L., Boulware, D. C., Beam, C. A., Hutton, J. C., Wenzlau, J. M., Greenbaum, C. J., Bingley, P. J., Krischer, J. P., Sosenko, J. M., Skyler, J. S., et al. (2012) · Diabetes Care · doi:10.2337/dc11-2081 · Cited by 104
Self-citationWenzlau, J. M., Moua, O., Sarkar, S. A., Yu, L., Rewers, M., Eisenbarth, G. S., Davidson, H. W., & Hutton, J. C. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1447.029 · Cited by 103
Self-citationGrijse, D. (2010) · doi:10.1007/s00125-009-1618-y · Cited by 94
Development of Autoantibodies in the TrialNet Natural History Study
Vehik, K., Beam, C. A., Mahon, J. L., Schatz, D. A., Haller, M. J., Sosenko, J. M., Skyler, J. S., Krischer, J. P., & for the TrialNet Natural History Study Group (2011) · Diabetes Care · doi:10.2337/dc11-0560 · Cited by 74
Self-citationthe Type 1 Diabetes TrialNet Study Group, Bingley, P. J., Boulware, D. C., & Krischer, J. P. (2015) · Diabetologia · doi:10.1007/s00125-015-3830-2 · Cited by 72
Self-citationGorus, F., Balti, E. V., Messaaoui, A., Demeester, S., Dalem, A. V., Costa, O. R., Dorchy, H., Mathieu, C., Gaal, L. V., Keymeulen, B., et al. (2017) · Diabetes Care · doi:10.2337/dc16-2228 · Cited by 68
Larsson, H. E., Vehik, K., Haller, M. J., Liu, X., Akolkar, B., Hagopian, W., Krischer, J. P., Lernmark, Å., She, J., Simell, O., et al. (2016) · Diabetes · doi:10.2337/db15-1180 · Cited by 67
Self-citationRising incidence of type 1 diabetes is associated with altered immunophenotype at diagnosis
Long, A. E., Gillespie, K. M., Rokni, S., Bingley, P. J., & Williams, A. J. K. (2012) · Diabetes · doi:10.2337/db11-0962 · Cited by 60
Self-citationEndesfelder, D., zu Castell, W., Bonifacio, E. E., Rewers, M., Hagopian, W., She, J., Lernmark, Å., Toppari, J., Vehik, K., Williams, A. J. K., et al. (2018) · Diabetes · doi:10.2337/db18-0594 · Cited by 49
Self-citationBauer, W., Veijola, R., Lempainen, J., Kiviniemi, M., Härkönen, T., Toppari, J., Knip, M., Gyenesei, A., & Ilonen, J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00421 · Cited by 46
Self-citationLong, A. E., Gooneratne, A. T., Rokni, S., Williams, A. J. K., & Bingley, P. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1952 · Cited by 45
Self-citationLong, A. E., Wilson, I. V., Becker, D. J., Libman, I. M., Arena, V. C., Wong, F. S., Steck, A. K., Rewers, M., Yu, L., Achenbach, P., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4591-5 · Cited by 44
Self-citationTörn, C., Liu, X., Hagopian, W., Lernmark, Å., Simell, O., Rewers, M., Ziegler, A., Schatz, D., Akolkar, B., Önengüt-Gümüşcü, S., et al. (2016) · Scientific Reports · doi:10.1038/srep27887 · Cited by 41
Self-citationImportance of Zinc Transporter 8 Autoantibody in the Diagnosis of Type 1 Diabetes in Latin Americans
Gomes, K. F. B., Semzezem, C., Batista, R., Fukui, R. T., Santos, A. S., Correia, M. R. S., Passos‐Bueno, M. R., & da Silva, M. E. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-00307-4 · Cited by 38
Lynch, K., Lee, H., Törn, C., Vehik, K., Krischer, J. P., Larsson, H. E., Haller, M. J., Hagopian, W., Rewers, M., She, J., et al. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.09.005 · Cited by 36
Self-citationIslet autoantibodies and their use in predicting insulin-dependent diabetes
Bonifacio, E. E., & Bingley, P. J. (1997) · Acta Diabetologica · doi:10.1007/s005920050072 · Cited by 32
Self-citationBalke, E. M., Balti, E. V., der Auwera, B. J. R. V., Weets, I., Costa, O. R., Demeester, S., Abrams, P. J., Casteels, K., Coeckelberghs, M., Tenoutasse, S., et al. (2018) · Diabetes Care · doi:10.2337/dc17-2462 · Cited by 29
Cited by
Chen, B., Yu, P., Chan, W. N., Xie, F., Zhang, Y., Liang, L., Leung, K. T., Lo, K. W., Yu, J., Tse, G. M. K., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01679-y · Cited by 420
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Self-citationSacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 203
Self-citationPhillip, M., Achenbach, P., Addala, A., Albanese-O’Neill, A., Battelino, T., Bell, K. J., Besser, R. E. J., Bonifacio, E. E., Colhoun, H. M., Couper, J., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06205-5 · Cited by 136
Self-citationKrischer, J. P., Liu, X., Lernmark, Å., Hagopian, W. A., Rewers, M. J., She, J.-X., Toppari, J., Ziegler, A.-G., Akolkar, B., TEDDY Study Group, et al. (2022) · Diabetes Care · doi:10.2337/dc21-2612 · Cited by 76
Self-citation
Metadata
- Authors
- Vehik, K., Bonifacio, E., Lernmark, Å., Yu, L., Williams, A., Schatz, D., Rewers, M., She, J.-X., Toppari, J., Hagopian, W., Akolkar, B., Ziegler, A. G., Krischer, J. P., The TEDDY Study Group, Rewers, M., Barbour, A., Bautista, K., Baxter, J., Felipe-Morales, D., Driscoll, K., Frohnert, B. I., Stahl, M., Gesualdo, P., Hoffman, M., Karban, R., Liu, E., Norris, J., Peacock, S., Shorrosh, H., Steck, A., Stern, M., Villegas, E., Waugh, K., Toppari, J., . Simell, O. G., Adamsson, A., Ahonen, S., Åkerlund, M., Hakola, L., Hekkala, A., Holappa, H., Hyöty, H., Ikonen, A., Ilonen, J., Jäminki, S., Jokipuu, S., Karlsson, L., Kero, J., Kähönen, M., Knip, M., Koivikko, M.-L., Koskinen, M., Koreasalo, M., Kurppa, K., Kytölä, J., Latva-aho, T., Lindfors, K., Lönnrot, M., Mäntymäki, E., Mattila, M., Miettinen, M., Multasuo, K., Mykkänen, T., Niininen, T., Niinistö, S., Nyblom, M., Oikarinen, S., Ollikainen, P., Othmani, Z., Pohjola, S., Rajala, P., Rautanen, J., Riikonen, A., Riski, E., Pekkola, M., Romo, M., Ruohonen, S., Simell, S., Sjöberg, M., Stenius, A., Tossavainen, P., Vähä-Mäkilä, M., Vainionpää, S., Varjonen, E., Veijola, R., Viinikangas, I., Virtanen, S. M., She, J.-X., Schatz, D., Hopkins, D., Steed, L., Bryant, J., Silvis, K., Haller, M., Gardiner, M., McIndoe, R., Sharma, A., Anderson, S. W., Jacobsen, L., Marks, J., Towe, P. D., Ziegler, A. G., Bonifacio, E., Gezginci, C., Heublein, A., Hohoff, E., Hummel, S., Knopff, A., Koch, C., Koletzko, S., Ramminger, C., Roth, R., Schmidt, J., Scholz, M., Stock, J., Warncke, K., Wendel, L., Winkler, C., Lernmark, Å., Agardh, D., Andrén Aronsson, C., Ask, M., Bennet, R., Cilio, C., Dahlberg, S., Engqvist, H., Ericson-Hallström, E., Björne Fors, A., Fransson, L., Gard, T., Hansen, M., Jisser, H., Johansen, F., Jonsdottir, B., Elding Larsson, H., Lindström, M., Lundgren, M., Maziarz, M., Månsson-Martinez, M., Melin, J., Mestan, Z., Nilsson, C., Ottosson, K., Rahmati, K., Ramelius, A., Salami, F., Sjöberg, A., Sjöberg, B., Törn, C., Wimar, Å., Hagopian, W. A., Killian, M., Cowen Crouch, C., Skidmore, J., Chavoshi, M., Meyer, A., Meyer, J., Mulenga, D., Powell, N., Radtke, J., Romancik, M., Roy, S., Schmitt, D., Zink, S., Becker, D., Franciscus, M., Dalmagro-Elias Smith, M., Daftary, A., Beth Klein, M., Yates, C., Krischer, J. P., Austin-Gonzalez, S., Avendano, M., Baethke, S., Burkhardt, B., Butterworth, M., Clasen, J., Cuthbertson, D., Eberhard, C., Fiske, S., Garmeson, J., Gowda, V., Heyman, K., Hsiao, B., Karges, C., Perez Laras, F., Li, Q., Liu, S., Liu, X., Lynch, K., Maguire, C., Malloy, J., McCarthy, C., Parikh, H., Remedios, C., Shaffer, C., Smith, L., Smith, S., Sulman, N., Tamura, R., Tewey, D., Toth, M., Uusitalo, U., Vehik, K., Vijayakandipan, P., Yang, J., Abbondondolo, M., Ballard, L., Brown, R., Dankyi, S., Hadley, D., Lee, H.-S., McLeod, W., Merrell, A., Meulemans, S., Quigley, R., Akolkar, B., Yu, L., Miao, D., Bingley, P., Williams, A., Chandler, K., Kelland, I., Ben Khoud, Y., Zahid, H., Randell, M., Hagopian, W., Chavoshi, M., Radtke, J., Zink, S., Erlich, H., Mack, S. J., Lisa Fear, A., Rich, S. S., Chen, W.-M., Onengut-Gumuscu, S., Farber, E., Roche Pickin, R., Davis, J., Davis, J., Gallo, D., Bonnie, J., Campolieto, P., Ke, S., Mulholland, N., Bourcier, K., Briese, T., Bennett Johnson, S., & Triplett, E.
- Affiliations
- University of Colorado Anschutz (US)
- University of Turku (FI)
- Augusta University (US)
- TUM Klinikum (DE)
- Lund University (SE)
- Pacific Northwest Research Institute (US)
- University of South Florida (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- University of Bristol (GB)
- ORCID
- Driscoll, Kimberly
- Frohnert, Brigitte I.
- Gesualdo, Patricia
- Liu, Edwin
- Norris, Jill
- Steck, Andrea
- Adamsson, Annika
- Hakola, Leena
- Hekkala, Anne
- Hyöty, Heikki
- Ilonen, Jorma
- Kero, Jukka
- Knip, Mikael
- Kurppa, Kalle
- Lindfors, Katri
- Lönnrot, Maria
- Mattila, Markus
- Miettinen, Maija
- Niinistö, Sari
- Oikarinen, Sami
- Riikonen, Anne
- Tossavainen, Päivi
- Vähä-Mäkilä, Mari
- Veijola, Riitta
- Virtanen, Suvi M.
- Hopkins, Diane
- Steed, Leigh
- Silvis, Katherine
- Haller, Michael
- McIndoe, Richard
- Sharma, Ashok
- Jacobsen, Laura
- Heublein, Anja
- Hohoff, Eva
- Hummel, Sandra
- Roth, Roswith
- Schmidt, Jennifer
- Warncke, Katharina
- Winkler, Christiane
- Agardh, Daniel
- Bennet, Rasmus
- Cilio, Corrado
- Lundgren, Markus
- Maziarz, Marlena
- Melin, Jessica
- Ramelius, Anita
- Salami, Falastin
- Törn, Carina
- Skidmore, Jennifer
- Roy, Shreya
- Burkhardt, Brant
- Clasen, Joanna
- Cuthbertson, David
- Heyman, Kathleen
- Li, Qian
- Liu, Xiang
- Lynch, Kristian
- Parikh, Hemang
- Remedios, Cassandra
- Uusitalo, Ulla
- Yang, Jimin
- Lee, Hye-Seung
- Quigley, Ryan
- Chandler, Kyla
- Mack, Steven J.
- Rich, Stephen S.
- Chen, Wei-Min
- Farber, Emily
- Davis, Jonathan
- Bonnie, Jessica
- Briese, Thomas
- Triplett, Eric
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-07-08
- Volume
- 43
- Issue
- 9
- Pages
- 2066-2073
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC7440899
- OpenAlex
- W3041031234
- Cited by
- 87
- References
- 43
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 17 · 2023: 15 · 2022: 13 · 2021: 14 · 2020: 1
- FWCI
- 6.29
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Explore Bristol Research (acceptedVersion, other-oa)
- Lund University Publications (Lund University) (submittedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- Site cant be reached (submittedVersion, other-oa)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (U01-DK-63829, U01-DK-63861, U01-DK-63821, U01-DK-63865, U01-DK-63863, U01-DK-63836, U01-DK-63790, U01-DK-100238, U01-DK-106955, U01-DK-112243, U01-DK-117483, U01-DK-95300, UC4-DK-63829, UC4-DK-63861, UC4-DK-63821, UC4-DK-63865, UC4-DK-63863, UC4-DK-63836, UC4-DK-95300, UC4-DK-100238, UC4-DK-106955, UC4-DK-112243, UC4-DK-117483, contract no. HHSN267200700014C)
- National Institute of Allergy and Infectious Diseases
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Institute of Environmental Health Sciences
- JDRF
- Centers for Disease Control and Prevention
- National Institutes of Health/National Center for Advancing Translational Sciences (UL1-TR-000064, UL1-TR-001082)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- type 1 diabetes, beta-cell autoantibodies, glutamic acid decarboxylase antibodies, zinc transporter 8 autoantibodies, TEDDY study, disease risk stratification
- MeSH terms
- Seroconversion, Zinc Transporter 8, Adolescent, Autoantibodies, Child, Child, Preschool, Diabetes Mellitus, Type 1, Female, Follow-Up Studies, Glutamate Decarboxylase, HLA-DQ Antigens, HLA-DR Antigens, Humans, Infant, Insulin Antibodies, Male, Risk Factors, Disease Progression, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.